Abstract
One possibility for the non-invasive imaging of encapsulated cell grafts is to label the lumen of cell embedding capsules with a redox-responsive probe, as an increased extracellular reducing potential can be considered as a marker of hypoxia-induced necrosis. A Gd(III)-HPDO3A-like chelate has been conjugated to glycol-chitosan through a redox-responsive disulphide bond to obtain a contrast agent for Magnetic Resonance Imaging (MRI). Such a compound can be interspersed with fibroblasts within the lumen of alginate-chitosan capsules. Increasing reducing conditions within the extracellular microenvironment lead to the reductive cleavage of the disulphide bond and to the release of gadolinium in the form of a low molecular weight, non-ionic chelate. The efflux of such chelate from capsules is readily detected by a decrease of contrast enhancement in T1-weighted MR images.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 12289-12293 |
| Numero di pagine | 5 |
| Rivista | Chemistry - A European Journal |
| Volume | 27 |
| Numero di pubblicazione | 48 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 25 ago 2021 |